the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes..
.
sign in to get notified via email when new comments are made..
.
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.
the state launched a review into the newspaper�s findings in late april.
.